New Delhi: The Government’s Subject Expert Committee (SEC) on Wednesday recommended granting regular market approval to Covishield and Covaxin Coronavirus vaccines, but with certain conditions.
The Serum Institute of India (SII) and Bharat Biotech had submitted their respective applications to the country’s drug regulator, the Drugs Controller General of India (DCGI), seeking full market authorisation for their vaccines. The vaccines are currently only authorised for emergency use in the country.
